187795-44-4

Basic information

• Product Name: 3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine
• Synonyms: 3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine;3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine(WXC06415)
• CAS NO: 187795-44-4
• Molecular Formula: C₁₃H₁₅N₃
• Molecular Weight: 213.2783
• Mol File: 187795-44-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine(187795-44-4)
• EPA Substance Registry System: 3-cyclobutyl-1-phenyl-1H-pyrazol-5-amine(187795-44-4)

Safety Data

• Hazardous Substances Data: 187795-44-4(Hazardous Substances Data)

Upstream product

• 59-88-1 phenylhydrazine hydrochloride 
• 118431-89-3 β-Cyclobutyl-β-oxopropionitrile 

Downstream Products

• 1448705-40-5 C₂₀H₁₈ClFN₄O 
• 1448705-39-2 C₂₀H₁₉BrN₄O 
• 1448705-38-1 C₂₁H₁₉F₃N₄O 
• 1448705-37-0 C₂₀H₁₉ClN₄O 

Relevant articles and documents

N-SULFONYLATED PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE

The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sj?gren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).